ArticleScientific reports2022

Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer.

Abdus Samad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.